Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an innovative approach to the stroke care pathway reduced costs by an average of EUR 2,848 (~USD 3,120) per patient. The retrospective analysis looked at data from the controlled single-center ANGIOCAT clinical trial conducted at the Vall d’Hebron University Hospital Stroke Unit (Barcelona, Spain)
Using real-world data from a hospital in China, the UC Riverside-led study found that individual characteristics, including age, weight, and additional illness determine which drug combinations most effectively reduce recurrence rates.
19 June 2023, Online.In recent years, researchers have begun using computational methods to screen those libraries in hopes of speeding up drug discovery.
The peer-reviewed journal Cell Reports Physical Science published research showing the efficacy of her AI-detection method, along with sufficient source code for others to replicate the tool.